Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.60 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | CRHBP | P24387 | 1/20 | 0.56 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL27291442 | 0.92 | MAPT (0.56) | MAPTHCAR3MAPK1MEN1KMT2A | |
| Alcohol SCHEMBL5697786 | 0.92 | MAPT (0.56) | MAPTHCAR3MAPK1MEN1KMT2A | |
| SCHEMBL7357317 | 0.90 | MAPT (0.55) | MAPTHCAR3MAPK1MEN1KMT2A | |
| Aniline SCHEMBL27777480 | 0.87 | MAPT (0.61) | MAPTHCAR3MAPK1MEN1KMT2A | |
| SCHEMBL4631056 | 0.85 | MAPT (0.54) | MAPTMAPK1MEN1KMT2AHTT | |
| SCHEMBL11554160 | 0.85 | MAPT (0.56) | MAPTHCAR3MAPK1MEN1KMT2A | |
| SCHEMBL10138690 | 0.84 | HCAR3 (0.53) | MAPTHCAR3MAPK1MEN1KMT2A | |
| SCHEMBL7996823 | 0.84 | MAPT (0.64) | MAPTHCAR3MEN1KMT2AHTT | |
| SCHEMBL31715811 | 0.84 | MAPT (0.73) | MAPTMAPK1MEN1KMT2AHTT | |
| SCHEMBL5350139 | 0.82 | MEN1 (0.52) | MAPTHCAR3MAPK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111689873-B | Preparation method of deuterated terbutaline | 北京理工大学 | 2021-04-23 | — | — | CN | claimed |
| CN-111763475-A | Single-component polyurethane waterproof coating | 湖北九阳防水材料科技有限公司 | 2020-10-13 | — | — | CN | claimed |
| CN-111689873-A | Preparation method of deuterated terbutaline | 北京理工大学 | 2020-09-22 | — | — | CN | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| EP-2346836-B1 | PROCESSES FOR THE PREPARATION OF BENDAMUSTINE | CEPHALON INC (US) | 2018-03-07 | — | — | EP | claimed |
| CN-102177140-B | For the preparation of the method for bendamustine | CEPHALON, INC. (US) | 2016-01-27 | — | — | CN | claimed |
| US-8420829-B2 | Processes for the preparation of bendamustine | CEPHALON, INC. (US) | 2013-04-16 | — | — | US | claimed |
| CN-102993102-A | Synthetic method of [1-methyl-2-(8'-octyl hydroxamic acid group)-5-N,N-bi(2'-chloroethyl)]-1H-benzimidazole | Hangzhou minsheng pharmaceutical group co ltd | 2013-03-27 | — | — | CN | claimed |
| US-20120291931-A1 | COMPOSITE COMPOUND INCLUDING EXPLOSIVE AND MODIFIER FOR EXPLOSIVE AND METHOD OF MANUFACTURE THEREOF | MCDERMOTT WILL & EMERY | 2012-11-22 | — | — | US | claimed |
| US-20110190509-A1 | Processes for the Preparation of Bendamustine | CEPHALON, INC. (US) | 2011-08-04 | — | — | US | claimed |
| EP-2346836-A1 | PROCESSES FOR THE PREPARATION OF BENDAMUSTINE | Cephalon, Inc. (US) | 2011-07-27 | — | — | EP | claimed |
| US-20100096050-A1 | MODIFIER FOR EXPLOSIVES | LIMITED LIABILITY COMPANY IFO | 2010-04-22 | — | — | US | claimed |
| WO-2010042568-A1 | PROCESSES FOR THE PREPARATION OF BENDAMUSTINE | CEPHALON, INC. (US) | 2010-04-15 | — | — | WO | claimed |
| WO-2006060654-A2 | PESTICIDAL COMPOSITIONS AND METHODS | DIVERGENCE, INC. (US) | 2006-06-08 | — | — | WO | claimed |
| US-20050203067-A1 | Pesticidal compositions and methods | DIVERGENCE, INC. | 2005-09-15 | — | — | US | claimed |
| US-12590066-B2 | Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-31 | — | — | US | disclosed |
| US-20240067952-A1 | REPROGRAMMING UROKINASE INTO AN ANTIBODY-RECRUITING ANTICANCER AGENT | UNIV YALE (US) | 2024-02-29 | — | — | US | disclosed |
| US-4033945-A | Water-soluble trisazo 8-amino-naphthol-1 dyes | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1977-07-05 | — | — | US | disclosed |
| US-4001408-A | SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESSES AND COMPOSITION INCLUDING THOSE | ROUSSEL-UCLAF (FR) | 1977-01-04 | — | — | US | disclosed |
| US-3984398-A | 1,5-Benzodiazepine-2,4-diones | ROUSSEL-UCLAF (FR) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190509-A1 | Processes for the Preparation of Bendamustine | THPO, FOLR1, FOLR2 | MAPT 976/4885HCAR3 3757/4885MAPK1 2235/4885 |
| US-20240067952-A1 | REPROGRAMMING UROKINASE INTO AN ANTIBODY-RECRUITING ANTICANCER AGENT | PLAUR, CD47, CD14 | MAPT 3491/4885HCAR3 498/4885MAPK1 3224/4885 |
| US-20050203067-A1 | Pesticidal compositions and methods | ACHE, DDT, PTMS | MAPT 3378/4885HCAR3 773/4885MAPK1 4785/4885 |
| US-12590066-B2 | Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CLIC1 | MAPT 4672/4885HCAR3 162/4885MAPK1 1791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.